Company Search:
Advanced Search
Sponsored Links
H. Lundbeck A/S Company Snapshot
H. Lundbeck A/S operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares H. Lundbeck A/S with three other pharmaceutical manufacturers in Europe: Stada Arzneimittel AG of Germany (2017 sales of 2.31 billion Euro [US$2.84 billion] of which 59% was Generics), Hikma Pharmaceuticals PLC of the United Kingdom (£1.49 billion [US$2.07 billion] ), and Ipsen SA which is based in France (2.01 billion Euro [US$2.47 billion] ).

Sales Analysis. H. Lundbeck A/S reported sales of 17.23 billion Danish Kroner (US$2.84 billion) for the year ending December of 2017. This represents an increase of 10.2% versus 2016, when the company's sales were 15.63 billion Danish Kroner. This was the third consecutive year of growth at H. Lundbeck A/S. Sales of Northera saw an increase that was more than double the company's growth rate: sales were up 51.2% in 2017, from 1.09 billion Danish Kroner to 1.64 billion Danish Kroner. H. Lundbeck A/S also saw significant increases in sales in Onfi (up 25.4% to 3.02 billion Danish Kroner) and Brintellix/trintellix (up 50.4% to 1.66 billion Danish Kroner) and Abilify Maintena (up 19.5% to 1.33 billion Danish Kroner) and Rexulti (up 51.0% to 1.25 billion Danish Kroner) . Not all segments of H. Lundbeck A/S experienced an increase in sales in 2017: sales of Xenazine fell 33.2% to 1.05 billion Danish Kroner. H. Lundbeck A/S also experienced decreases in sales in Cipralex (down 5.9% to 2.37 billion Danish Kroner) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
H. Lundbeck A/S
  Stock Performance Chart for H. Lundbeck A/S
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 341.60
(Figures in Danish Kroner)
1 Week 0.7%   13 Weeks 5.4%  
4 Weeks 13.4%   52 Weeks 11.1%  
H. Lundbeck A/S Key Data:
  Ticker: LUN Country: Denmark
  Exchanges: CPH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 17,234,000,000
(Year Ending Jan 2018).
Employees: 4,976
  Currency: Danish Kroner Market Cap: 67,862,078,710
  Fiscal Yr Ends: December Shares Outstanding: 198,659,481
  Share Type: Stammaktie Closely Held Shares: 137,351,918
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.